Zobrazeno 1 - 10 of 36 pro vyhledávání: '"A.T.A. FAZEKAS"'
1
Untersuchungen über die glukokortikoide Steuerung des Zinkstoffwechsels
Autor: F.W. Ahnefeld, A.T.A. Fazekas, L. Fodor
Publikováno v: Transfusion Medicine and Hemotherapy. 2:210-213
In der vorliegenden Arbeit wird ein möglicher Zusammenhang zwischen ACTH-Belastung, Kortisolausschüttung und Serum-zinkspiegel untersucht. Es zeigte sich, daβ, während unter ACTH-Belastung die Kortisolausschüttung physiologischerweise rea-giert,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::34f36b26e996b9193b26a102f7cce551
https://doi.org/10.1159/000219618
Zobrazit plný text záznamu
2
New hormonal treatment in cancer of the prostate: Combined administration of an LHRH agonist and an antiandrogen
Autor: J. G. Laberge, J.M. Husson, F. A. Lefebvre, A.T.A. Fazekas, André Dupont, G. Monfette, Emond J, Jean-Pierre Raynaud, A. Bélanger, Fernand Labrie, Lionel Cusan
Publikováno v: Journal of Steroid Biochemistry. 19:999-1007
At doses which have no or minimal inhibitory effect when administered alone, the LHRH agonist [D-Ser(TBU)6,des-Gly-NH10(2)] LHRH ethylamide (HOE-766) and the antiandrogen RU-23908 administered simultaneously cause a marked inhibition of ventral prost
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7775fef5378d89d7991098446f84b0d
https://doi.org/10.1016/0022-4731(83)90046-8
Zobrazit plný text záznamu
4
Sensitivity of luteinizing hormone and gonadal steroid responses to single intranasal administration of an LHRH agonist (Hoe-766) in young normal adult men
Autor: Belanger A, Fernand Labrie, André Lemay, Faure N, Jean-Pierre Raynaud, M. Von Der Ohe, A.T.A. Fazekas
Publikováno v: Journal of endocrinological investigation. 5(6)
While intranasal administration of the potent LHRH agonist [D-Ser (TBL))6, des-Gly-NH210] LHRH ethylamide, Hoe-766,at the doses of 50 or 10μg, has little effect on serum LH levels, doses of 200, 500, 1250 or 2500μg cause a rapid and marked stimulat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f5c1f368c63a8d14b776b4ac71be6f
https://pubmed.ncbi.nlm.nih.gov/6820372
Zobrazit plný text záznamu
6
New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist
Autor: A.T.A. Fazekas, J.M. Husson, André Dupont, Bélanger A, Fernand Labrie, Jean-Pierre Raynaud, F. A. Lefebvre, Lionel Cusan
Publikováno v: Hormone research. 18(1-3)
Treatment with an LHRH agonist (HOE-766) alone causes an almost complete blockage of testicular testosterone formation in rat and man. In order to neutralize androgens of adrenal origin, a pure antiandrogen (RU-23908) was given in combination with th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e46967dcd47e2ffd0cf5421c1057fab
https://pubmed.ncbi.nlm.nih.gov/6411578
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje